Equities analysts predict that Allstate (NYSE:ALL) will post sales of $8.30 billion for the current quarter, according to Zacks. Three analysts have issued estimates for Allstate’s earnings, with the highest sales estimate coming in at $8.32 billion and the lowest estimate coming in at $8.27 billion. Allstate posted sales of $9.30 billion during the same quarter last year, which would indicate a negative year over year growth rate of 10.8%. The business is scheduled to report its next quarterly earnings results after the market closes on Tuesday, May 1st.
On average, analysts expect that Allstate will report full year sales of $33.71 billion for the current financial year, with estimates ranging from $33.63 billion to $33.78 billion. For the next fiscal year, analysts expect that the business will report sales of $35.17 billion per share, with estimates ranging from $34.90 billion to $35.47 billion. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that cover Allstate.
Allstate (NYSE:ALL) last announced its earnings results on Wednesday, February 7th. The insurance provider reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.56. Allstate had a net margin of 8.28% and a return on equity of 12.57%. The company had revenue of $8.20 billion for the quarter, compared to the consensus estimate of $8.09 billion. During the same period in the previous year, the business earned $2.17 EPS. The company’s revenue was up 3.8% on a year-over-year basis.
ALL has been the topic of several recent analyst reports. Keefe, Bruyette & Woods downgraded shares of Allstate from a “market perform” rating to an “underperform” rating in a research note on Tuesday, January 2nd. Citigroup boosted their target price on shares of Allstate from $111.00 to $112.00 and gave the company a “buy” rating in a research note on Tuesday, March 27th. Deutsche Bank cut their target price on shares of Allstate from $102.00 to $100.00 and set a “hold” rating on the stock in a research note on Friday, February 9th. Wells Fargo reissued a “hold” rating and set a $100.00 target price on shares of Allstate in a research note on Monday, April 2nd. Finally, ValuEngine raised shares of Allstate from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $101.79.
Shares of NYSE:ALL opened at $97.39 on Wednesday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.25 and a current ratio of 0.25. Allstate has a 12-month low of $80.75 and a 12-month high of $105.36. The firm has a market cap of $34,846.77, a price-to-earnings ratio of 14.51, a PEG ratio of 1.40 and a beta of 0.94.
The business also recently declared a quarterly dividend, which was paid on Monday, April 2nd. Stockholders of record on Monday, March 5th were paid a $0.46 dividend. The ex-dividend date of this dividend was Friday, March 2nd. This is an increase from Allstate’s previous quarterly dividend of $0.37. This represents a $1.84 dividend on an annualized basis and a dividend yield of 1.89%. Allstate’s dividend payout ratio is 27.42%.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Cambridge Investment Research Advisors Inc. increased its stake in shares of Allstate by 3.2% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 54,205 shares of the insurance provider’s stock worth $5,676,000 after acquiring an additional 1,699 shares during the last quarter. Wagner Wealth Management LLC acquired a new position in Allstate during the fourth quarter worth $894,000. Xact Kapitalforvaltning AB increased its position in Allstate by 8.1% during the fourth quarter. Xact Kapitalforvaltning AB now owns 52,346 shares of the insurance provider’s stock worth $5,481,000 after buying an additional 3,912 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its position in Allstate by 929.2% during the fourth quarter. Massmutual Trust Co. FSB ADV now owns 89,126 shares of the insurance provider’s stock worth $6,364,000 after buying an additional 80,466 shares during the last quarter. Finally, CNB Bank acquired a new position in Allstate during the fourth quarter worth $429,000. 77.37% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: This story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/25/allstate-all-expected-to-announce-quarterly-sales-of-8-30-billion.html.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, engages in property and casualty insurance, and life insurance businesses in the United States and Canada. The company's Allstate Protection segment sells private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance policies; other personal lines products, including renter, condominium, landlord, boat, umbrella, and manufactured home insurance policies; and commercial lines products under the Allstate, Esurance, and Encompass brand names.
Get a free copy of the Zacks research report on Allstate (ALL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.